Aerobic vs Resistance Exercise in Post-menopausal Women With Type 1 Diabetes
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age45-75
SponsorUniversity of Alberta
About this trial
Participants will be asked to wear a continuous glucose monitor for at least three days on three separate occasions. One testing session will be a no-exercise resting control session (90 minutes). One will be a moderate aerobic exercise session (30 minutes of exercise, 60 minutes of recovery), and the third will be a moderate weight-lifting session (\~30 minutes of exercise, 60 minutes of recovery).The investigators will measure changes in blood glucose during exercise by drawing blood during and after exercise. Post-exercise glucose trends will be examined using continuous glucose monitoring.
Eligibility criteria
Qualifiers
type 1 diabetes, diagnosed for at least one year
post-menopause (at least one year since last menstrual period), or have had a hysterectomy and bilateral salpingo oophorectomy
able to perform aerobic and resistance exercise
able to visit the lab in Edmonton, Alberta (University of Alberta)
Disqualifiers
HbA1c > 9.9 %
frequent and unpredictable hypoglycemia
change in insulin management strategy within the last 2 months
blood pressure > 140 / 95
Trial design
Treatments tested in this trial
- Aerobic Exercise
- Resistance Exercise
- No exercise
Treatment groups
20 Participants
are divided into 1 treatment groupLocations
2Alberta Diabetes InstituteT6G 2R3, EdmontonAlberta, Canada
Institut de recherches cliniques de MontréalH2W 1R7, MontrealQuebec, Canada
Sponsors and collaborators
University of Alberta
Lead sponsor
Women and Children's Health Research Institute, Canada
Collaborator
Source ClinicalTrials.gov